IBB’s Top Performers: PETX Gains on Its First FDA Approval
IBB’s top performers for March 21, 2016, were Cara Therapeutics (CARA), OvaScience (OVAS), Sarepta Therapeutics (SRPT), and Aratana Therapeutics (PETX).
Bears Had the Upper Hand on February 29: IBB Lost 2.8%
The bears had the last word in February as the markets ended the month in the red. The slowdown of the Chinese economy continued to weigh on markets as its manufacturing sector shrank for the seventh month in a row.